August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Hidehito Horinouchi: Real-World Outcomes of Tarlatamab in SCLC
Apr 3, 2025, 09:27

Hidehito Horinouchi: Real-World Outcomes of Tarlatamab in SCLC

Hidehito Horinouchi, Assistant Chief at National Cancer Center Hospital, shared an article Fabian J. Bolte and his colleagues authored on X:

Real-World Outcomes of Tarlatamab in SCLC.

Special considerations are required for patients with brain metastasis due to the increased risk of severe.

Dr. Fabian J. Bolte.”

Real-World Outcomes of Tarlatamab in Small Cell Lung Cancer, Including Patients with Untreated Brain Metastases

Authors: Fabian J. Bolte et al.

Hidehito Horinouchi

Further Reading:

Tarlatamab (Imdelltra): What Patients Need to Know About

Tarlatamab (Imdelltra): Uses in Cancer, Side Effects, Dosages, Expectations, and More